Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



GEN Podcasts

Back to Item »

ROUNDTABLE DISCUSSION ON BIOTECH/PHARMA DEALS

- Martina Molsbergen, VP, Business Development, Crucell; Barbara Yanni, Chief Licensing Officer, Merck & Co.; David Colpman, Senior VP, Business Development, Shire Pharmaceuticals; and Joern-Peter Halle, Head, Early-Stage Licensing, Merck Serono, a division of Merck KGaA



  • Click here to Login or to Register for free.

    You will be taken back to your selected item after Login/Registration.

GEN Poll

More » Poll Results » Archive »

The Price of BRCA Testing

Is getting a genetic test worth the multi-thousand dollar price?

Suggest a Poll